Key result
The myocardial ischemic score, combining radial pulse spectrum harmonics with albumin-to-creatinine ratio and ankle-brachial index, identified moderate to severe silent myocardial ischemia.
Why the study?
Does a Myocardial Ischemic Score (MIS) incorporating radial pulse spectrum analysis improve the identification of moderate to severe silent myocardial ischemia in asymptomatic high-risk type 2 diabetic patients?
Cross-Sectional (n=195)
No
Does a Myocardial Ischemic Score (MIS) incorporating radial pulse spectrum analysis improve the identification of moderate to severe silent myocardial ischemia in asymptomatic high-risk type 2 diabetic patients?
Adding radial pulse spectrum analysis to traditional risk markers (ABI and ACR) significantly improves the risk stratification and identification of moderate to severe silent myocardial ischemia in asymptomatic type 2 diabetic patients.
Answers are grounded in this paper and cite their sources.
May aid noninvasive detection of silent ischemia; leaves open prospective validation before clinical adoption.
Diabetic patients with silent myocardial ischemia (SMI) have elevated rates of morbidity and mortality and need intensive care and monitoring. An early predictor of SMI may lead to early diagnosis and medical treatment to prevent progression and adverse clinical events. Therefore, this paper was aimed to evaluate the radial pulse spectrum as risk markers to improve the risk stratification of SMI in type-2 diabetic patients; 195 diabetic patients at high-risk of SMI were enrolled. All patients underwent myocardial perfusion imaging and radial pressure wave measurement. The spectrum analysis of the radial pressure wave was calculated and transformed into Fourier series coefficients Cns and Pns. The risk of SMI (odds ratio: 4.46, 95%, C.I. 1.61-12.4, [Formula: see text]) was raised in diabetic patients classified high-risk group by C2. Multivariable regression analysis showed that C2 ([Formula: see text]) and ankle-brachial index [(ABI) [Formula: see text])] were related to SMI ([Formula: see text] and [Formula: see text]). The myocardial ischemic score (MIS), combining C2, C3, and P5, the albumin-to-creatinine ratio (ACR), and ABI, presented an excellent risk stratification performance in enrolled patients (odds ratio: 5.78, 95%, C.I. 2.29-14.6, [Formula: see text]). The area under receiver operating characteristic curves for C2, C3, P5, ABI, ACR, and MIS were 0.66, 0.60, 0.68, 0.51, 0.56, and 0.74, respectively, in identifying SMI. This paper demonstrated that C2 was independently associated with the extent of SMI in multivariable regression analysis. Odds ratio and chi-square tests reflected that C2 could be an important marker for the risk stratification of SMI. Furthermore, MIS, adding radial pulse spectrum analysis to ACR and ABI, could significantly improve the risk stratification of SMI in type-2 diabetic patients compared to any single risk factor.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2018) conducted a cross-sectional in Type 2 diabetes at high risk of silent myocardial ischemia (n=195). Myocardial Ischemic Score (MIS) including radial pulse spectrum analysis vs. Low MIS score was evaluated on Moderate to severe silent myocardial ischemia (Summed Stress Score ≥ 9) (OR 5.78, 95% CI 2.29-14.6, p=<0.01). The myocardial ischemic score, combining radial pulse spectrum harmonics with albumin-to-creatinine ratio and ankle-brachial index, identified moderate to severe silent myocardial ischemia.
Synapse has enriched 10 related papers. Consider them for comparative context: